PT  - JOURNAL ARTICLE
AU  - D E Duggan
AU  - K F Hooke
AU  - S S Hwang
TI  - Kinetics of the tissue distributions of sulindac and metabolites. Relevance to sites and rates of bioactivation.
DP  - 1980 Jul 01
TA  - Drug Metabolism and Disposition
PG  - 241--246
VI  - 8
IP  - 4
4099  - http://dmd.aspetjournals.org/content/8/4/241.short
4100  - http://dmd.aspetjournals.org/content/8/4/241.full
SO  - Drug Metab Dispos1980 Jul 01; 8
AB  - Sulindac (sulfoxide) is a prodrug in reversible metabolic equilibrium with its pharmacologically active metabolite, the corresponding sulfide. Following simultaneous parenteral injection of sulfoxide-14C and sulfide-3H at equivalent dosage, all labeled species in the plasma of rats and guinea pigs and in representative tissues were determined at various times. Rate constants for sulfoxide in equilibrium or formed from sulfide, calculated from the rates of interchange of the two labels in plasma, are still higher than those approximated from earlier, single-label studies, and indicate turnovers of total body pools every 45 and 8.5 min in rat and guinea pig, respectively. From the time-course of tissue/plasma ratios of endogenous labeled species, it can be concluded that kidney and liver are major sites of bioactivation of the prodrug, with significant sulfoxide leads to sulfide activity present in all tissues examined. At steady state, tissue concentrations of each redox form are determined by the ratio of the metabolic rate constants for the two opposing biotransformations and by unique tissue/plasma distributive constants for each redox form, resulting in all tissues, except lung, and at all times examined, in a sulfide/sulfoxide ratio greater than one.